1. Clinical Overview
A fixed-dose combination (FDC) of three agents targeting different pathways in cardiovascular disease management. Aspirin is an irreversible cyclooxygenase-1 (COX-1) inhibitor providing antiplatelet action. Rosuvastatin is a competitive HMG-CoA reductase inhibitor for potent LDL-C reduction and plaque stabilization. Clopidogrel is a thienopyridine P2Y12 ADP receptor antagonist providing synergistic antiplatelet activity. This combination is primarily indicated for secondary prevention in patients with established atherosclerotic cardiovascular disease (ASCVD) to reduce the risk of major adverse cardiovascular events (MACE).
| Onset | Duration | Bioavailability |
|---|---|---|
| Aspirin: 30-60 minutes (antiplatelet effect). Rosuvastatin: LDL-C reduction begins within 1 week, maximal effect in 4 weeks. Clopidogrel: Active metabolite inhibits platelets within 2 hours of a loading dose; with a 75mg maintenance dose, steady-state inhibition is achieved in 3-7 days. | Aspirin: Irreversible platelet inhibition lasts for the lifespan of the platelet (7-10 days). Rosuvastatin: Pharmacodynamic effect persists for several days; requires daily dosing for continuous enzyme inhibition. Clopidogrel: Irreversible platelet inhibition lasts for the platelet lifespan. | Aspirin: ~50% (rapidly hydrolyzed to salicylate in gut/liver). Rosuvastatin: ~20%. Clopidogrel: >50% (but requires hepatic bioactivation; the active metabolite bioavailability is low). |
2. Mechanism of Action
This combination provides a multi-pronged attack on atherothrombosis. Aspirin irreversibly acetylates platelet cyclooxygenase-1 (COX-1), inhibiting thromboxane A2 synthesis, a potent platelet aggregator and vasoconstrictor. Clopidogrel irreversibly inhibits the P2Y12 subtype of the ADP receptor on the platelet surface, blocking ADP-mediated platelet activation and aggregation. Their antiplatelet effects are synergistic. Rosuvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, leading to upregulation of LDL receptors and increased clearance of LDL from the bloodstream. It also exerts pleiotropic effects including plaque stabilization, improved endothelial function, and anti-inflammatory activity.
3. Indications & Uses
- Secondary prevention of atherothrombotic events in patients with established Atherosclerotic Cardiovascular Disease (ASCVD)
- Post-Percutaneous Coronary Intervention (PCI) with stent implantation (Dual Antiplatelet Therapy - DAPT) for recommended duration, combined with high-intensity statin therapy
- Post-Acute Coronary Syndrome (ACS: Unstable Angina, NSTEMI, STEMI) for secondary prevention
4. Dosage & Administration
Adult Dosage: One tablet (Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 75mg) orally once daily. Rosuvastatin is usually taken in the evening but can be taken anytime; consistency is key. For ACS/PCI: Typically part of DAPT (with clopidogrel) for 6-12 months, often followed by single antiplatelet therapy, but statin (rosuvastatin) is lifelong.
Administration: Swallow the tablet whole with a glass of water, with or without food. Taking with food may reduce GI upset from aspirin. Do not crush or chew. For patients unable to swallow, alternative forms (e.g., dispersible aspirin, separate statin) should be considered. Administer rosuvastatin at a consistent time each day.
5. Side Effects
Common side effects may include:
- Increased bleeding tendency (bruising, epistaxis, gingival bleeding)
- Dyspepsia, heartburn, nausea, abdominal pain
- Headache, dizziness
- Constipation, diarrhea
- Myalgia (muscle pain) - with rosuvastatin
- Fatigue
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Warfarin / DOACs (Apixaban, Rivaroxaban, Dabigatran) | Profoundly increased risk of major and fatal bleeding | Contraindicated / High |
| NSAIDs (Ibuprofen, Diclofenac, Naproxen) | Increased GI bleeding risk; pharmacodynamic interaction with aspirin | High |
| Proton Pump Inhibitors (Omeprazole, Esomeprazole) | Omeprazole/Esomeprazole are CYP2C19 inhibitors; may reduce clopidogrel activation. Pantoprazole is preferred. | Moderate |
| Fluconazole, Voriconazole (CYP2C19 inhibitors) | Reduce conversion of clopidogrel to active metabolite, diminishing antiplatelet effect | Moderate |
| Rifampicin (CYP inducer) | May reduce clopidogrel and rosuvastatin efficacy | Moderate |
| Cyclosporine, Gemfibrozil | Significantly increase rosuvastatin plasma levels, raising risk of myopathy/rhabdomyolysis. Avoid combination. | High |
| Warfarin | Aspirin displaces warfarin from protein binding and impairs platelet function, increasing INR and bleeding risk. | High |
| SSRIs (e.g., Sertraline, Escitalopram) | Increased bleeding risk due to impaired platelet serotonin uptake | Moderate |
| Systemic corticosteroids | Increased risk of GI ulceration and bleeding | Moderate |
7. Patient Counselling
- DO take the tablet exactly as prescribed, at the same time each day.
- DO inform all your doctors and dentists about all medications you are taking, especially before any surgery or dental procedure.
- DO report any unusual bleeding (gums, nose, easy bruising, black/tarry stools, blood in urine/vomit) immediately.
- DO have regular blood tests (LFT, lipid profile, renal function) as advised by your doctor.
- DONT stop taking this medicine suddenly without consulting your doctor, as it may increase your risk of heart attack or stroke.
- DONT take other NSAIDs (like ibuprofen, diclofenac) for pain relief without consulting your doctor.
- DONT consume excessive alcohol.
- DONT take any other over-the-counter medicines, vitamins, or herbal supplements (like Ginkgo biloba, Garlic) without checking with your doctor/pharmacist.
8. Toxicology & Storage
Overdose: ASPIRIN: Mild: Tinnitus, hearing loss, nausea, vomiting, hyperventilation. Severe: Metabolic acidosis, respiratory alkalosis, fever, dehydration, coma, cardiovascular collapse, renal failure. CLOPIDOGREL: Increased bleeding risk, prolonged bleeding time. ROSUVASTATIN: Expected to intensify adverse effects like myalgia, hepatotoxicity. Acute overdose data limited.
Storage: Store in a cool, dry place, protected from light and moisture. Keep the container tightly closed. Store at room temperature (preferably below 30°C). Keep out of reach and sight of children.